Connealy Pamela Ann 4
4 · Pyxis Oncology, Inc. · Filed Nov 27, 2024
Insider Transaction Report
Form 4
Connealy Pamela Ann
CFO & COO
Transactions
- Purchase
Common Stock
2024-11-26$2.00/sh+5,450$10,900→ 1,115,743 total(indirect: By Trust) - Purchase
Common Stock
2024-11-26$1.96/sh+83,400$163,464→ 1,199,143 total(indirect: By Spouse)
Footnotes (2)
- [F1]These shares are held directly by the Personal Def Ben Pln Trust, a revocable trust for which the Reporting Person and their spouse are the trustees.
- [F2]The price reported in column 4 is a weighted-average price.These shares were purchased in multiple transactions at prices ranging from $1.93 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.